Literature DB >> 1313311

Gender and histologic type variations in smoking-related risk of lung cancer.

R C Brownson1, J C Chang, J R Davis.   

Abstract

We conducted a registry-based case-control study to examine the relation between smoking and lung cancer by gender and histologic type. Our analyses were based on 14,596 cases and 36,438 age-matched controls. Relative risk associated with ever-smoking, and level of smoking was consistently higher in females than males for all lung cancers combined (ever-smoking odds ratios: 12.7 for females and 9.1 for males) and for each histologic type except adenocarcinoma. Female-male differences in relative risk were larger in younger age groups. The largest estimates of the attributable fraction due to smoking were observed for small cell carcinoma (97% in females and 91% in males); conversely, the smallest value was noted for adenocarcinoma (86% in females). Although our study was unable to measure absolute risk, our findings, other recent studies, and contemporary female smoking patterns raise concerns that female smokers may assume a proportionally greater burden of lung cancer morbidity and mortality in the future.

Entities:  

Mesh:

Year:  1992        PMID: 1313311     DOI: 10.1097/00001648-199201000-00012

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  28 in total

Review 1.  Lung cancer in women.

Authors:  Angela M Coscio; Jennifer Garst
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 2.  Systematic review with meta-analysis of the epidemiological evidence in the 1900s relating smoking to lung cancer.

Authors:  Peter N Lee; Barbara A Forey; Katharine J Coombs
Journal:  BMC Cancer       Date:  2012-09-03       Impact factor: 4.430

Review 3.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

4.  Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Michele L Coté; Mei Liu; Stefano Bonassi; Monica Neri; Ann G Schwartz; David C Christiani; Margaret R Spitz; Joshua E Muscat; Gad Rennert; Katja K Aben; Angeline S Andrew; Vladimir Bencko; Heike Bickeböller; Paolo Boffetta; Paul Brennan; Hermann Brenner; Eric J Duell; Eleonora Fabianova; John K Field; Lenka Foretova; Søren Friis; Curtis C Harris; Ivana Holcatova; Yun-Chul Hong; Dolores Isla; Vladimir Janout; Lambertus A Kiemeney; Chikako Kiyohara; Qing Lan; Philip Lazarus; Jolanta Lissowska; Loic Le Marchand; Dana Mates; Keitaro Matsuo; Jose I Mayordomo; John R McLaughlin; Hal Morgenstern; Heiko Müeller; Irene Orlow; Bernard J Park; Mila Pinchev; Olaide Y Raji; Hedy S Rennert; Peter Rudnai; Adeline Seow; Isabelle Stucker; Neonila Szeszenia-Dabrowska; M Dawn Teare; Anne Tjønnelan; Donatella Ugolini; Henricus F M van der Heijden; Erich Wichmann; John K Wiencke; Penella J Woll; Ping Yang; David Zaridze; Zuo-Feng Zhang; Carol J Etzel; Rayjean J Hung
Journal:  Eur J Cancer       Date:  2012-03-19       Impact factor: 9.162

5.  Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO).

Authors:  Claire H Kim; Yuan-Chin Amy Lee; Rayjean J Hung; Sheila R McNallan; Michele L Cote; Wei-Yen Lim; Shen-Chih Chang; Jin Hee Kim; Donatella Ugolini; Ying Chen; Triantafillos Liloglou; Angeline S Andrew; Tracy Onega; Eric J Duell; John K Field; Philip Lazarus; Loic Le Marchand; Monica Neri; Paolo Vineis; Chikako Kiyohara; Yun-Chul Hong; Hal Morgenstern; Keitaro Matsuo; Kazuo Tajima; David C Christiani; John R McLaughlin; Vladimir Bencko; Ivana Holcatova; Paolo Boffetta; Paul Brennan; Eleonora Fabianova; Lenka Foretova; Vladimir Janout; Jolanta Lissowska; Dana Mates; Peter Rudnai; Neonila Szeszenia-Dabrowska; Anush Mukeria; David Zaridze; Adeline Seow; Ann G Schwartz; Ping Yang; Zuo-Feng Zhang
Journal:  Int J Cancer       Date:  2014-03-25       Impact factor: 7.396

6.  Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA.

Authors:  Liang Wang; Jeremiah A Aakre; Ruoxiang Jiang; Randolph S Marks; Yanhong Wu; Jun Chen; Stephen N Thibodeau; V Shane Pankratz; Ping Yang
Journal:  J Thorac Oncol       Date:  2010-06       Impact factor: 15.609

7.  Are women who smoke at higher risk for lung cancer than men who smoke?

Authors:  Sara De Matteis; Dario Consonni; Angela C Pesatori; Andrew W Bergen; Pier Alberto Bertazzi; Neil E Caporaso; Jay H Lubin; Sholom Wacholder; Maria Teresa Landi
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

8.  Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer.

Authors:  Yian Wang; Weidong Wen; Yijun Yi; Zhongqiu Zhang; Ronald A Lubet; Ming You
Journal:  Cancer Prev Res (Phila)       Date:  2009-11-24

Review 9.  Incidence and risk of lung cancer in HIV-infected patients.

Authors:  Wenli Hou; Jun Fu; Yuanyuan Ge; Jian Du; Shucheng Hua
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-28       Impact factor: 4.553

Review 10.  Treatment options for small cell lung cancer - do we have more choice?

Authors:  M Puglisi; S Dolly; A Faria; J S Myerson; S Popat; M E R O'Brien
Journal:  Br J Cancer       Date:  2010-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.